EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy

Guanzhi Ye, Gaojian Pan, Xiaolei Zhu, Ning Li, Hongming Liu, Guojun Geng, Jie Jiang

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05911-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Guanzhi Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, No 55, Zhenhai Road, Xiame…. Hauptthemen laut MEDLINE: Lymphatic Metastasis, Recurrent Laryngeal Nerve, Esophageal Neoplasms, Esophageal Squamous Cell Carcinoma. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Fujian Province, Xiamen Municipal Bureau of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This research aimed to clarify the metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma and to investigate appropriate strategies for lymph node dissection. METHODS: Patients with thoracic esophageal squamous cell carcinoma receiving esophagectomy from December 2020 to April 2024 were retrospectively analyzed. Risk factors for subcarinal, right and left recurrent laryngeal nerve lymph nodes metastasis were determined by chi-square test and multivariate logistic regression analysis. We visualized the metastasis rates of these specific lymph nodes based on the different clinicopathological characteristics. Correlation between subcarinal, right and left recurrent laryngeal lymph nodes metastasis and postoperative complications were also analyzed. RESULTS: A total of 503 thoracic esophageal squamous carcinoma patients who underwent esophagectomy were enrolled. The metastasis rates of subcarinal, right and left recurrent laryngeal nerve lymph nodes were 10.3%, 10.3%, and 10.9%, respectively. The lymphovascular invasion status and tumor location were the significant predictors for subcarinal and right recurrent laryngeal nerve lymph nodes metastasis, respectively (P < 0.001 and P = 0.013). For left recurrent laryngeal nerve lymph node metastasis, younger age (P = 0.020) and presence of lymphovascular invasion (P = 0.009) were significant risk factors. Additionally, pulmonary infection is the most frequent postoperative complication in patients with dissection of subcarinal, right and left recurrent laryngeal lymph nodes. There was no significant difference in the incidence of anastomotic leakage (P = 0.872), pulmonary infection (P = 0.139), chylothorax (P = 0.702), and hoarseness (P = 0.179) between the subcarinal lymph node dissection cohort and the reservation cohort. The incidence of hoarseness significantly increased in both right (P = 0.042) and left (P = 0.010) recurrent laryngeal nerve lymph nodes dissection cohorts compared by the reservation cohorts, with incidence rates of 5.9% and 6.7%, respectively. CONCLUSIONS: The metastasis rates of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma were all over 10%. The dissection of subcarinal lymph nodes does not increase postoperative complications risk, while recurrent laryngeal nerve lymph nodes dissection significantly increases the incidence of hoarseness. Thus, lymph node dissection of subcarinal lymph nodes should be conducted routinely, while recurrent laryngeal nerve lymph nodes dissection may be selectively performed in specific patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic MetastasisRecurrent Laryngeal NerveEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaLymph NodesEsophagectomyLymph Node ExcisionHumansMaleFemaleMiddle AgedRetrospective StudiesAgedNeoadjuvant TherapyAdultRisk FactorsPostoperative Complications

Stichwörter der Autor:innen

Esophageal squamous cell carcinomaPostoperative complicationRecurrent laryngeal nerve lymph node metastasisSubcarinal lymph node metastasis

Autor:innen und Institutionen

  • Department of Thoracic Surgery, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China.
  • Department of Thoracic Surgery, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China. ggj622@126.com.
  • Department of Thoracic Surgery, School of Medicine, The First Affiliated Hospital of Xiamen University, Xiamen University, No 55, Zhenhai Road, Xiamen, Fujian, 361003, China. jiangjie06@126.com.

Förderung

  • Natural Science Foundation of Fujian Province
  • Xiamen Municipal Bureau of Science and Technology

Zitieren

APA

Ye, G., Pan, G., Zhu, X., Li, N., Liu, H., Geng, G., & Jiang, J. (2024). Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05911-2

Vancouver

Ye G, Pan G, Zhu X, Li N, Liu H, Geng G, et al. Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05911-2

BibTeX
@article{Ye2024,
  author = {Ye, Guanzhi and Pan, Gaojian and Zhu, Xiaolei and Li, Ning and Liu, Hongming and Geng, Guojun and Jiang, Jie},
  title = {Metastatic patterns of subcarinal, right and left recurrent laryngeal nerve lymph nodes in thoracic esophageal squamous cell carcinoma without neoadjuvant therapy},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05911-2}
}
Kostenlos starten →